Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Osteoporosis 1Musculoskeletal Diseases 1Hyperparathyroidism 1Humoral Hypercalcemia Of Malignancy 1Endocrine System Diseases 1Bone Diseases, Endocrine 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Parathyroid Hormone × Clear all
NCT01333267 2014-12-05

One Week Comparison Study of PTH and PTHrP Infusions

University of Pittsburgh

Phase 1 Withdrawn
Head & Neck

Humoral Hypercalcemia Of Malignancy, Bone Diseases, Endocrine, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡